cisatracurium besylate
Generic: cisatracurium besylate
Labeler: slate run pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
cisatracurium besylate
Generic Name
cisatracurium besylate
Labeler
slate run pharmaceuticals, llc
Dosage Form
INJECTION
Routes
Active Ingredients
cisatracurium besylate 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70436-113
Product ID
70436-113_14793b7b-0e90-7b75-e063-6394a90a9c5a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216538
Listing Expiration
2026-12-31
Marketing Start
2023-12-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70436113
Hyphenated Format
70436-113
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cisatracurium besylate (source: ndc)
Generic Name
cisatracurium besylate (source: ndc)
Application Number
ANDA216538 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82) / 10 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "14793b7b-0e90-7b75-e063-6394a90a9c5a", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199211"], "spl_set_id": ["e06c4d57-bfc7-45ad-b1cd-b5b88dc43b50"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-113-82", "marketing_start_date": "20231201"}], "brand_name": "Cisatracurium besylate", "product_id": "70436-113_14793b7b-0e90-7b75-e063-6394a90a9c5a", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "70436-113", "generic_name": "Cisatracurium besylate", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA216538", "marketing_category": "ANDA", "marketing_start_date": "20231201", "listing_expiration_date": "20261231"}